ArticlePediatric rheumatology online journal2025

Long-term safety of canakinumab in patients with systemic juvenile idiopathic arthritis: 5-year results from the Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry.

Colleen Correll et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.